BIICX
Price
$10.70
Change
+$0.01 (+0.09%)
Updated
Jun 2 closing price
Net Assets
10.53B
CAPCX
Price
$9.75
Change
+$0.05 (+0.52%)
Updated
Jun 2 closing price
Net Assets
677.56M
Interact to see
Advertisement

BIICX vs CAPCX

Header iconBIICX vs CAPCX Comparison
Open Charts BIICX vs CAPCXBanner chart's image
BIICX vs CAPCX Comparison Chart in %
View a ticker or compare two or three
VS
BIICX vs. CAPCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIICX is a StrongBuy and CAPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BIICX has more cash in the bank: 10.5B vs. CAPCX (678M). BIICX pays higher dividends than CAPCX: BIICX (5.91) vs CAPCX (2.72). BIICX was incepted earlier than CAPCX: BIICX (18 years) vs CAPCX (33 years). CAPCX (1.87) is less costly to investors than BIICX (0.68). BIICX is a more actively managed with annual turnover of: 99.00 vs. CAPCX (27.00). CAPCX has a lower initial minimum investment than BIICX: CAPCX (1500) vs BIICX (2000000). CAPCX annual gain was more profitable for investors over the last year : 14.84 vs. BIICX (10.56). BIICX (22.59) and CAPCX (22.53) have equivalent 5 years return.
BIICXCAPCXBIICX / CAPCX
Total Expense Ratio0.571.7433%
Annual Report Gross Expense Ratio0.681.8736%
Fund Existence18 years33 years-
Gain YTD3.8494.53985%
Front LoadN/AN/A-
Min. Initial Investment20000001500133,333%
Min. Initial Investment IRAN/A250-
Net Assets10.5B678M1,549%
Annual Yield % from dividends5.912.72217%
Returns for 1 year10.5614.8471%
Returns for 3 years32.6336.2690%
Returns for 5 years22.5922.53100%
Returns for 10 years69.6866.03106%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRGSX27.930.20
+0.72%
BlackRock Advantage Global R
GLCTX34.09N/A
N/A
Goldman Sachs Large Cap Gr Insghts Inv
PFGKX35.34N/A
N/A
Victory Pioneer Fundamental Growth R6
MSVVX5.26N/A
N/A
MetLife Small Company Equity Investor
ETLCX16.59N/A
N/A
Eventide Large Cap Focus C